$APPF

AppFolio, Inc. Announces Second Quarter 2026 Financial Results

AppFolio (NASDAQ: APPF) reported Q2 2026 results for the quarter ended June 30. Revenue rose 19% year over year to $281 million. GAAP operating income increased 31% to $53 million. Full-year 2026 revenue guidance was raised to $1.117-$1.127 billion and non-GAAP operating margin to 26.5%-28.0%.

Original reporting
Published Jul 23, 2026, 10:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 10:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$APPF
Bullish
high confidence
Mentioned
$APPF
Relevance
8/10
alphai data visualization · based on itnewsonline.com
Decision brief

The 30-second read

$APPFBullishMed
01

Why it matters

Traders can update valuation models using the raised full-year revenue range and the higher non-GAAP operating margin range, alongside quarterly operating income and cash flow strength.

02

Market read

Raised FY revenue and non-GAAP margin ranges plus strong Q2 operating income and operating cash flow are the core repricing inputs.

03

What to watch

The release emphasizes AI adoption, but it does not quantify AI contribution to revenue or margins, leaving uncertainty around sustainability of the operating leverage.

Relevance 8/10Novelty 8/10Timing: after-hours earnings release and same-day 2:00 p.m. PT conference call

Background

AppFolio is a real estate software platform company; this is its Q2 2026 earnings release with updated FY 2026 guidance.

Company-level read

Ticker impact

$APPFBullishHigh confidence
Context

AppFolio reported Q2 2026 revenue up 19% to $281M, GAAP operating income up 31% to $53M, and raised FY revenue guidance to $1.117-$1.127B.

Expected impact

Likely positive near-term bias as traders reprice FY 2026 revenue and non-GAAP margin expectations.

Evidence & confidence

The article discloses both quarterly performance metrics and an updated full-year outlook with specific ranges, which typically drives earnings-model revisions.

Market effects

Reinforces demand strength and monetization momentum in real estate software/proptech, potentially supporting peer sentiment around recurring revenue and margin expansion.

Limited direct regional read-through; primarily US-listed software/proptech sentiment.

Low global spillover beyond the real estate software niche.

Counterpoint

Profitability growth may be partially driven by non-GAAP adjustments and could face normalization risk if customer acquisition or AI-driven efficiency benefits slow.

Key entities

  • AppFolio, Inc.

    NASDAQ-listed real estate software provider reporting Q2 2026 results and raising FY 2026 guidance.

  • Shane Trigg

    Chairman and CEO quoted on momentum, revenue milestone, and AI-driven performance outcomes.

Related articles

$APPFHigh

APPFOLIO INC (APPF): Results of Operations and Financial Condition

APPFOLIO INC (APPF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 appfq22026exhibit991.htm EX-99.1 Document AppFolio, Inc. Announces Second Quarter 2026 Financial Results Strong 2026 Continues with 19% Revenue Growth and Expanding Profitability SANTA BARBARA, Calif., July 23, 2026 -- AppFolio, Inc. (NASDAQ: APPF) ("AppFolio" or the "C

$DRIMedAI 8/10

DRI Healthcare Reports Second Quarter 2026 Results and New Board Appointment

DRI Healthcare Trust (TSX: DHT.UN, DHT.U) reported Q2 2026 results for the quarter ended June 30, 2026: total income $50.1M, total cash receipts $46.5M, and adjusted EBITDA $42.6M. It repurchased 89,513 units at $11.65 and paid a $0.11/unit distribution. After quarter-end, it exercised a put option on Ekterly for about $178M and received FDA approval for Lumvoa (veligrotug), triggering $75M milestone payments.

$LGNDMed

Ligand Pharmaceuticals Incorporated Q2 2026 Earnings Call Summary

Ligand Pharmaceuticals reported Q2 2026 results and discussed its XOMA Royalty acquisition, adding 120+ assets and extending cash flow duration through 2040. Management cited 32% YoY royalty revenue growth and expects 2026 royalty revenue of $225M-$250M with cash opex halved since 2022. Ligand issued a $700M zero-coupon convertible, raised 2026 adjusted EPS guidance to $9.00-$9.50, and expects accretion from XOMA in 2H26 and 2027.

$KDPMed

Keurig Dr Pepper Inc. Q2 2026 Earnings Call Summary

Keurig Dr Pepper reported Q2 2026 results that exceeded expectations, citing double-digit U.S. Refreshment Beverages growth and day-one integration of JDE Peet's. Dr Pepper Zero Sugar grew 30% in retail sales and energy reached 9% market share. U.S. Coffee faced margin pressure from hedging and tariffs. KDP reaffirmed low double-digit EPS growth for 2026 and low-double-digit legacy growth at the high end of 4% to 6%.

$TAPMed

Molson Coors Beverage Company Q2 2026 Earnings Call Summary

Molson Coors reported Q2 2026 volume pressure tied to an energy and inflation shock after conflict in Iran, plus stronger promotions and geopolitical uncertainty in EMEA and APAC. The company reaffirmed FY2026 guidance, citing improving U.S. industry volumes, 1% to 2% annual U.S. price increases, and Midwest Premium aluminum COGS above $130 million, partly hedged. It also outlined a $450 million cost-savings plan and Atomic Brands integration.